Fresenius Net Working Capital from 2010 to 2025

FMS Stock  USD 24.31  0.05  0.21%   
Fresenius Medical Net Working Capital yearly trend continues to be comparatively stable with very little volatility. Net Working Capital will likely drop to about 1.5 B in 2025. From the period from 2010 to 2025, Fresenius Medical Net Working Capital quarterly data regression had r-value of  0.49 and coefficient of variation of  45.51. View All Fundamentals
 
Net Working Capital  
First Reported
2020-03-31
Previous Quarter
2.2 B
Current Value
2.3 B
Quarterly Volatility
967.2 M
 
Covid
Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 246 M, Total Revenue of 11.7 B or Gross Profit of 3.8 B, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0286 or PTB Ratio of 0.84. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
  
Check out the analysis of Fresenius Medical Correlation against competitors.

Latest Fresenius Medical's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Fresenius Medical Care over the last few years. It is Fresenius Medical's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fresenius Medical's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Fresenius Net Working Capital Regression Statistics

Arithmetic Mean1,268,019,556
Geometric Mean1,112,394,236
Coefficient Of Variation45.51
Mean Deviation421,290,639
Median1,074,414,000
Standard Deviation577,101,373
Sample Variance333046T
Range2.4B
R-Value0.49
Mean Square Error270654.2T
R-Squared0.24
Significance0.05
Slope59,570,302
Total Sum of Squares4995689.9T

Fresenius Net Working Capital History

20251.5 B
20242.3 B
20232.6 B
20221.7 B
2021709 M
20201.1 B
2019157.9 M

About Fresenius Medical Financial Statements

Fresenius Medical shareholders use historical fundamental indicators, such as Net Working Capital, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Working Capital2.3 B1.5 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.